Corbus Pharmaceuticals Holdings, Inc. Fair Value Adjustment of Warrants
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Fair Value Adjustment of Warrants of $6.22 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2021-05-13
- Corbus Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for the quarter ending 2021-03-31 was $6.22M, a 0.00% change year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for the quarter ending 2020-12-31 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for the quarter ending 2020-09-30 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for the quarter ending 2020-06-30 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for fiscal 2020 was $6.22M, a 0.00% change from fiscal 2019.
- Corbus Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for fiscal 2019 was $6.22M, a 0.00% change from fiscal 2018.
- Corbus Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for fiscal 2018 was $6.22M.
- Corbus Pharmaceuticals Holdings, Inc. fair value adjustment of warrants for fiscal 2014 was $28.45K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2021-03-31 | $6.22M 10-Q · filed 2021-05-13 | $6.22M derived: sum of 2 quarters · filed 2021-05-13 | $6.22M derived: sum of 3 quarters · filed 2021-05-13 | $6.22M derived: sum of 4 quarters · filed 2021-05-13 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $0.00 derived: sum of 2 quarters · filed 2021-03-15 | $0.00 derived: sum of 3 quarters · filed 2021-03-15 | $6.22M 10-K · filed 2021-03-15 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09 | $0.00 derived: sum of 2 quarters · filed 2020-11-09 | $6.22M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31 | $6.22M 10-Q/A · filed 2020-08-31 | ||
| 2020-03-31 | $6.22M 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | $6.22M 10-K · filed 2020-03-16 | |||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $6.22M 10-Q · filed 2019-08-08 | ||
| 2019-03-31 | $6.22M 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | $6.22M 10-K · filed 2019-03-12 | |||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-10 | $0.00 10-Q · filed 2015-11-10 | ||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $0.00 derived: sum of 2 quarters · filed 2016-03-28 | $29.97K derived: sum of 3 quarters · filed 2016-03-28 | $28.45K 10-K · filed 2016-03-28 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-10 | $29.97K derived: sum of 2 quarters · filed 2015-11-10 | $28.45K 10-Q · filed 2015-11-10 | $4.56K derived: sum of 4 quarters · filed 2015-11-10 |
| 2014-06-30 | $29.97K 10-Q · filed 2015-08-13 | $28.45K 10-Q · filed 2015-08-13 | $4.56K derived: sum of 3 quarters · filed 2015-08-13 | |
| 2014-03-31 | -$1.52K 10-Q · filed 2015-05-13 | -$25.41K derived: sum of 2 quarters · filed 2015-05-13 | ||
| 2013-12-31 | -$23.89K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-10 | -$1.98K 10-K · filed 2015-02-10 | ||
| 2013-09-30 | $21.91K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |